Adefovir dipivoxil [clinicaltrials_resource:42d53b14c9a9117cd0a957e79d1e8185]
The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected Children [clinicaltrials:NCT00000843]Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320 [clinicaltrials:NCT00000885]A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir [clinicaltrials:NCT00000892]A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients [clinicaltrials:NCT00000912]The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs [clinicaltrials:NCT00001087]Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients [clinicaltrials:NCT00002128]A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3 [clinicaltrials:NCT00002161]A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient [clinicaltrials:NCT00002184]A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated With Anti-HIV Drugs [clinicaltrials:NCT00002206]Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children [clinicaltrials:NCT00002219]Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir [clinicaltrials:NCT00002220]Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients [clinicaltrials:NCT00002234]The Safety and Effectiveness of Bis-POM PMEA in HIV-Infected Patients [clinicaltrials:NCT00002346]The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs [clinicaltrials:NCT00002379]Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations [clinicaltrials:NCT00002398]Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment [clinicaltrials:NCT00002419]A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive Patients [clinicaltrials:NCT00002426]A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV [clinicaltrials:NCT00033163]Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) [clinicaltrials:NCT00051077]
intervention [clinicaltrials_vocabulary:intervention]
Adefovir dipivoxil [clinicaltrials_resource:42d53b14c9a9117cd0a957e79d1e8185]
Bio2RDF identifier
42d53b14c9a9117cd0a957e79d1e8185
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:42d53b14c9a9117cd0a957e79d1e8185
intervention name [clinicaltrials_vocabulary:intervention-name]
Adefovir dipivoxil
identifier
clinicaltrials_resource:42d53b14c9a9117cd0a957e79d1e8185
title
Adefovir dipivoxil
@en
type
label
Adefovir dipivoxil [clinicaltrials_resource:42d53b14c9a9117cd0a957e79d1e8185]
@en